133 related articles for article (PubMed ID: 36593782)
1. Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert
Erfani P; Gaga E; Hakizimana E; Kayitare E; Mugunga JC; Shyirambere C; Milner DA; Shulman LN; Ruhangaza D; Fadelu T
Bull World Health Organ; 2023 Jan; 101(1):10-19. PubMed ID: 36593782
[TBL] [Abstract][Full Text] [Related]
2. Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country.
Mugabe M; Ho KE; Ruhangaza D; Milner D; Rugwizangoga B; Chu VC; Wu NC; Rizo A; Weidler JM; Wong W; Bates M; Brock JE
Am J Clin Pathol; 2021 Oct; 156(5):766-776. PubMed ID: 34050358
[TBL] [Abstract][Full Text] [Related]
3. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
Wu NC; Wong W; Ho KE; Chu VC; Rizo A; Davenport S; Kelly D; Makar R; Jassem J; Duchnowska R; Biernat W; Radecka B; Fujita T; Klein JL; Stonecypher M; Ohta S; Juhl H; Weidler JM; Bates M; Press MF
Breast Cancer Res Treat; 2018 Nov; 172(2):327-338. PubMed ID: 30120700
[TBL] [Abstract][Full Text] [Related]
4. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
[TBL] [Abstract][Full Text] [Related]
5. Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
Janeva S; Parris TZ; Nasic S; De Lara S; Larsson K; Audisio RA; Olofsson Bagge R; Kovács A
BMC Cancer; 2021 Apr; 21(1):439. PubMed ID: 33879115
[TBL] [Abstract][Full Text] [Related]
6. XPERT
Borges PCC; Spencer HB; Barbosa C; Costa V; Furtado A; Leal MC; Lopes C; Ferreira D; Carvalho AL; Dos-Santos-Silva I; Santos LL
Ecancermedicalscience; 2023; 17():1530. PubMed ID: 37138965
[TBL] [Abstract][Full Text] [Related]
7. Health system costs of a breast cancer early diagnosis programme in a rural district of Rwanda: a retrospective, cross-sectional economic analysis.
Nambaziira R; Niteka LC; Dusengimana JMV; Ruhumuriza J; Bhangdia KP; Mugunga JC; Uwineza ML; Rugema V; Erfani P; Shyirambere C; Shulman LN; Rabideau M; Pace LE
BMJ Open; 2022 Jun; 12(6):e062357. PubMed ID: 35772820
[TBL] [Abstract][Full Text] [Related]
8. Cost of Providing Quality Cancer Care at the Butaro Cancer Center of Excellence in Rwanda.
Neal C; Rusangwa C; Borg R; Tapela N; Mugunga JC; Pritchett N; Shyirambere C; Ntakirutimana E; Park PH; Shulman LN; Mpunga T
J Glob Oncol; 2018 Sep; 4():1-7. PubMed ID: 30241219
[TBL] [Abstract][Full Text] [Related]
9. Health Facility Cost of Cesarean Delivery at a Rural District Hospital in Rwanda Using Time-Driven Activity-Based Costing.
Odhiambo J; Ruhumuriza J; Nkurunziza T; Riviello R; Shrime M; Lin Y; Rusangwa C; Omondi JM; Toma G; Nyirimodoka A; Mpunga T; Hedt-Gauthier BL
Matern Child Health J; 2019 May; 23(5):613-622. PubMed ID: 30600515
[TBL] [Abstract][Full Text] [Related]
10. Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material.
Berghuis AMS; van Deurzen CHM; Koffijberg H; Terstappen LWMM; Sleijfer S; IJzerman MJ
Breast Cancer Res Treat; 2019 Jun; 175(2):451-458. PubMed ID: 30756285
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of mRNA-Based Testing of
Erber R; Hartmann A; Fasching PA; Ruebner M; Stöhr R; Beckmann MW; Zentgraf M; Popp V; Weidler J; Simon I; Becker S; Huebner H; Fischer J; Guerini Rocco E; Viale G; Cayre A; Penault-Llorca F; Caniego Casas T; Pérez-Miés B; Palacios J; Jank P; Denkert C; Khoury L; Mairinger T; Ferrazzi F
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572945
[TBL] [Abstract][Full Text] [Related]
12. Use of Web-based training for quality improvement between a field immunohistochemistry laboratory in Nigeria and its United States-based partner institution.
Oluwasola AO; Malaka D; Khramtsov AI; Ikpatt OF; Odetunde A; Adeyanju OO; Sveen WE; Falusi AG; Huo D; Olopade OI
Ann Diagn Pathol; 2013 Dec; 17(6):526-30. PubMed ID: 24095629
[TBL] [Abstract][Full Text] [Related]
13. The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer.
Rosin G; Hannelius U; Lindström L; Hall P; Bergh J; Hartman J; Kere J
BMC Cancer; 2012 Feb; 12():79. PubMed ID: 22375924
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
Allott EH; Geradts J; Sun X; Cohen SM; Zirpoli GR; Khoury T; Bshara W; Chen M; Sherman ME; Palmer JR; Ambrosone CB; Olshan AF; Troester MA
Breast Cancer Res; 2016 Jun; 18(1):68. PubMed ID: 27349894
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
16. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
Varga Z; Lebeau A; Bu H; Hartmann A; Penault-Llorca F; Guerini-Rocco E; Schraml P; Symmans F; Stoehr R; Teng X; Turzynski A; von Wasielewski R; Gürtler C; Laible M; Schlombs K; Joensuu H; Keller T; Sinn P; Sahin U; Bartlett J; Viale G
Breast Cancer Res; 2017 May; 19(1):55. PubMed ID: 28490348
[TBL] [Abstract][Full Text] [Related]
17. Male circumcision at different ages in Rwanda: a cost-effectiveness study.
Binagwaho A; Pegurri E; Muita J; Bertozzi S
PLoS Med; 2010 Jan; 7(1):e1000211. PubMed ID: 20098721
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hormone-induced mRNA and protein biomarker expression changes in breast cancer cells.
Bernhardt SM; Dasari P; Glynn DJ; Townsend AR; Price TJ; Ingman WV
Breast Cancer Res Treat; 2021 Jun; 187(3):681-693. PubMed ID: 34057651
[TBL] [Abstract][Full Text] [Related]
19. Cost of Treating Pediatric Cancer at the Butaro Cancer Center of Excellence in Rwanda.
Neal C; Rusangwa C; Borg R; Mugunga JC; Kennell-Heiling S; Shyirambere C; Pritchett N; Muhayimana C; Ntakirutimana E; Tapela N; Park PH; Shulman LN; Mpunga T
J Glob Oncol; 2018 Nov; 4():1-7. PubMed ID: 30433841
[TBL] [Abstract][Full Text] [Related]
20. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
